Precigen PGEN
NASDAQ PGEN
$7.11 -0.03 (-0.49%)
As of: Sep 4, 2026 · 3:59 PM EDT

Precigen (PGEN) Other Accumulated Expenses (2012 - 2026)

Precigen (PGEN) posted quarterly Other Accumulated Expenses of $12.5 million for Q1 2026, up 90.03% year-over-year from $6.6 million in Q1 2025, and up 13.54% quarter-over-quarter from $11.0 million in Q4 2025.

Analysis

Precigen (PGEN) Other Accumulated Expenses (2012 - 2026) Analysis & Trends

Precigen (PGEN) has reported Other Accumulated Expenses for 15 consecutive years, with $12.5 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Other Accumulated Expenses rose 90.03% year-over-year to $12.5 million; the TTM figure through Mar 2026 stood at $12.5 million (up 90.03% YoY), while the FY2025 annual figure was $11.0 million, up 128.45% from the prior year.
  • Other Accumulated Expenses rose to $12.5 million in Q1 2026 per PGEN's latest filing, from $11.0 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $22.9 million in Q1 2023 and bottomed at $3.3 million in Q2 2023.
  • Historically, Other Accumulated Expenses has averaged $8.7 million across 5 years, with a median of $7.3 million in 2024.
  • Annual changes were most pronounced in 2024 — Other Accumulated Expenses sank 68.12% — and 2025, when it surged 128.45%.
  • Precigen's Other Accumulated Expenses stood at $5.0 million in 2022, then rose by 24.53% to $6.2 million in 2023, then decreased by 22.67% to $4.8 million in 2024, then soared by 128.45% to $11.0 million in 2025, then increased by 13.54% to $12.5 million in 2026.
  • Business Quant data shows PGEN's Other Accumulated Expenses at $12.5 million in Q1 2026, $11.0 million in Q4 2025, and $10.8 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Precigen 2.53 Bn 2.53 Bn 52.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 16.21 Mn
Mar 31, 2026 12.48 Mn
Dec 31, 2025 10.99 Mn
Sep 30, 2025 10.82 Mn
Jun 30, 2025 9.51 Mn
Mar 31, 2025 6.57 Mn
Dec 31, 2024 4.81 Mn
Sep 30, 2024 5.68 Mn
Jun 30, 2024 6.64 Mn
Mar 31, 2024 7.30 Mn
Dec 31, 2023 6.22 Mn
Sep 30, 2023 4.12 Mn
Jun 30, 2023 3.26 Mn
Mar 31, 2023 22.89 Mn
Dec 31, 2022 5.00 Mn
Sep 30, 2022 11.69 Mn
Jun 30, 2022 9.67 Mn
Mar 31, 2022 10.49 Mn
Dec 31, 2021 7.82 Mn
Sep 30, 2021 11.26 Mn